- Home
- SWBI vs EIKN Comparison
SWBI vs EIKN Comparison
Compare SWBI & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SWBI | EIKN |
|---|---|---|
| Founded | 1852 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 637.4M | 631.0M |
| IPO Year | 2000 | 2026 |
Fundamental Metrics
Financial Performance| Metric | SWBI | EIKN |
|---|---|---|
| Price | $13.02 | $9.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $14.00 | ★ $25.60 |
| AVG Volume (30 Days) | ★ 588.6K | 508.6K |
| Earning Date | 06-17-2026 | 03-30-2026 |
| Dividend Yield | ★ 3.37% | N/A |
| EPS Growth | ★ 36.67 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $523,845,000.00 | N/A |
| Revenue This Year | $7.61 | N/A |
| Revenue Next Year | $3.72 | N/A |
| P/E Ratio | $219.17 | ★ N/A |
| Revenue Growth | ★ 10.36 | N/A |
| 52 Week Low | $8.14 | $7.90 |
| 52 Week High | $17.56 | $16.50 |
Technical Indicators
Market Signals| Indicator | SWBI | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 41.28 |
| Support Level | $12.09 | $8.43 |
| Resistance Level | $15.60 | $10.20 |
| Average True Range (ATR) | 0.52 | 0.83 |
| MACD | 0.07 | -0.28 |
| Stochastic Oscillator | 54.58 | 13.54 |
Price Performance
Historical ComparisonAbout SWBI Smith & Wesson Brands Inc.
Smith & Wesson Brands Inc is a U.S.-based company engaged in manufacturing and selling firearms. It operates under one reportable segment: Firearms, which includes firearms distribution and manufacturing services. The company manufactures handguns, long guns, sporting rifles, shooting gear, and suppressor products. The company sells its products under the Smith and Wesson and Gemtech brands, which are used for defense, law enforcement, hunting, and sporting purposes. Geographically, it sells products globally, with maximum income being generated by the U.S. market from its handgun products.
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.